Adenoviral oncolysis in head and neck squamous cell carcinoma
Laryngo-rhino-otologie(2023)
摘要
Introduction HNSCC are amenable to adenoviral oncolytic tumor virotherapy because adenoviral (AdV) vectors can proliferate tumor-specifically in these cells. However, AdV vectors are mostly based on AdV serotype 5, which is limited in its applicability for in vivo treatment due to pre-existing immunity in the population and unfavorable liver tropism. To develop new, improved personalized AdV vectors, we investigated the potential of naturally occurring human adenoviruses to infect and possibly kill primary HNSCC.
更多查看译文
关键词
adenoviral oncolysis,neck squamous cell carcinoma,squamous cell carcinoma
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要